Las Vegas, NV -- (SBWIRE) -- 10/03/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds work diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies: PING AN INS CO ADR (OTCMKTS:PNGAY), Hopto Inc (OTCBB:HPTO), Tullow Oil Plc (UK) (OTCMKTS:TUWOY), Generex Biotechnology Corporation (OTCMKTS:GNBT)
PING AN INS CO ADR (OTCMKTS:PNGAY) opened the session at $14.92, remained amid the day range of $14.90 - $15.09, and closed the session at $15.05. The stock showed a positive performance of 0.40% in previous trading session. The stock gained a volume of 566,280 shares and the average volume of the stock remained 27,943 shares.
What was the Moving Force behind PNGAY on Bullish Run? Read This Research Report
Hopto Inc (OTCBB:HPTO) traded with volume of 145,199 shares in the prior session and the average volume of the stock remained 170,808 shares. The 52 week range of the stock remained $0.21 - $0.80. The stock showed a positive movement of 2.26% and closed its session at $0.589. The market capitalization of the stock remained 57.79 million. hopTo Inc, formerly GraphOn Corporation, is developers of software productivity products for mobile devices such as tablets and smartphones and application publishing software solutions. The Company's product, which is called hopTo, will be marketed to both consumers and businesses.
For How Long HPTO will fight for Profitability? Read This Trend Analysis report
Tullow Oil Plc (UK) (OTCMKTS:TUWOY) exchanged 26,036 shares and the average volume remained 52,911 shares. The stock dropped -0.84% and closed the session at $8.25. The beta of the stock remained 1.03.
Why Should Investors Buy TUWOY After the Recent Fall? Just Go Here and Find Out
Generex Biotechnology Corporation (OTCMKTS:GNBT) gained volume of 1.62 million shares, while the average volume remained 1.83 million shares. The stock advanced 4.92% and finished the session at $0.0320. The EPS of the stock remained -0.02. The three month trend remained negative -8.83%. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity.
For How Long GNBT Gloss will Attract Investors? Find out via this report
About: Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock reader, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wall Street. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)